chevron_leftBack
As of 24 April 2025, Yuki Gosei Kogyo Co., Ltd. has a market cap of $36.74M USD, ranking #26537 globally and #3004 in Japan. It ranks #2859 in the Basic Materials sector, and #389 in the Chemicals industry.
Key Stats
Market Cap
$36.74MUSD
5.23B JPY
Enterprise Value
$87.76MUSD
12.56B JPY
Revenue (TTM)
$104.19MUSD
14.85B JPY
EBITDA (TTM)
$15.9MUSD
2.28B JPY
Net Income (TTM)
$6.25MUSD
891.0M JPY
EBITDA Margin
15%
Profit Margin
6%
PE Ratio
5.9
Company Profile
Country (HQ)
Sector
Basic Materials
Industry
Chemicals
CEO
Seiichiro Matsumoto
open_in_new
Employees
290
Founded
1947
Website
yuki-gosei.co.jp
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 2.5% | 2.5% | -13% | -8.6% | -8.3% | -17% |
Upcoming Earnings
Earnings Date
Thu, May 15
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
4531
有機合成薬品工業株式会社
ISIN: JP3946400003
Shares Out.:
Shares Outstanding:
21.543M1
Shares Float:
12.222M2
|
249 JPY |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Yuki Gosei Kogyo Co., Ltd.
Yuki Gosei Kogyo Co., Ltd. researches, develops, manufactures, and markets fine chemical products in Japan and internationally. It offers food additives, pharmaceuticals, and industrial and agricultural chemicals; and glycine, glycine compounds, nicotinic acid amide, isoniazid, drug intermediates, and cosmetic ingredients. The company also provides amino acid, pyridine, piperidine, silicon, and other compounds; DNA, nucleoside, and protamine; and active pharmaceutical ingredients. In addition, it engages in the contract manufacturing of pharmaceuticals and chemical products. Yuki Gosei Kogyo Co., Ltd. was founded in 1947 and is headquartered in Tokyo, Japan.
